The digital health for cardiovascular market size is expected to see exponential growth in the next few years. It will grow to $137.87 billion in 2030 at a compound annual growth rate (CAGR) of 22.6%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac care, rising investments in ai-driven diagnostics, expansion of cloud-based healthcare platforms, growing focus on preventive cardiovascular care, increasing adoption of real-time patient monitoring. Major trends in the forecast period include increasing adoption of remote cardiac monitoring solutions, rising use of wearable ecg devices, growing integration of ai-based diagnostic software, expansion of telecardiology platforms, enhanced focus on continuous patient monitoring.
The growing adoption of telehealth services is expected to drive the expansion of the digital health for cardiovascular care market in the coming years. Telehealth services involve the delivery of healthcare remotely through phone calls, video consultations, or mobile applications, enabling patients to connect with healthcare providers without visiting medical facilities. The increasing use of telehealth is largely attributed to its convenience, particularly for individuals managing chronic conditions such as cardiovascular diseases. Digital health solutions for cardiovascular care support telehealth by facilitating remote monitoring and virtual consultations, thereby improving patient access to care. These solutions enhance healthcare efficiency by enabling real-time data collection, supporting accurate diagnosis and treatment planning, and minimizing the need for in-person visits. For example, in November 2024, according to the Australian Digital Health Agency, an Australia-based government organization, the Patient Experiences 2023-24 report indicated that among individuals who had a telehealth consultation, 89.2% stated they would choose telehealth again if available, up from 87.7% in 2022-23. Therefore, the rising adoption of telehealth services is contributing to the growth of the digital health for cardiovascular care market.
Leading companies operating in the digital health for cardiovascular care market are concentrating on developing advanced services, such as telemedicine solutions, to improve remote patient monitoring, expand access to healthcare, and enable timely interventions for people with heart-related conditions. Telemedicine services involve the use of digital communication technologies, including video conferencing, mobile applications, and remote monitoring devices, to deliver medical consultations, diagnoses, and treatments remotely. For instance, in January 2025, Withings, a France-based consumer electronics company, introduced Cardio Check-Up, a telemedicine service offered as part of its Withings Plus subscription. Through this service, subscribers can use compatible Withings devices that collect electrocardiogram data to receive professional evaluations of their heart health. The service provides four cardiologist reports annually, generated from the collected data and delivered through collaboration with Heartbeat Health.
In January 2025, Myant Corp., a Canada-based textile computing company, acquired mmHg Inc. for an undisclosed amount. Through this acquisition, Myant seeks to strengthen its product offerings by incorporating remote blood pressure monitoring and cardiovascular risk reduction technologies, while expanding its footprint in the US market and enhancing its capabilities in chronic disease management. mmHg Inc. is a US-based digital health company focused on remote patient monitoring solutions, particularly in the field of cardiovascular care.
Major companies operating in the digital health for cardiovascular market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, HeartFlow Inc., Viz.ai Inc., Bardy Diagnostics Inc., Ultromics Limited, RSIP Vision Ltd., Cardiologs Technologies SAS, Aktiia SA, FibriCheck, Cleerly Inc., AliveCor Inc., iRhythm Technologies Inc., Preventice Solutions (Boston Scientific), Eko Health Inc., BioTelemetry Inc., Withings Health Solutions.
North America was the largest region in the digital health for cardiovascular market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital health for cardiovascular market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital health for cardiovascular market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the digital health for cardiovascular market by increasing costs of imported sensors, semiconductors, wearable components, cloud infrastructure hardware, and diagnostic software tools. Healthcare providers in North America and Europe are most affected due to dependence on imported digital health technologies, while Asia-Pacific faces higher costs in device manufacturing and export activities. These tariffs are increasing system deployment costs and slowing large-scale rollouts. However, they are also encouraging domestic technology development, localized device assembly, and regional innovation in digital cardiovascular health solutions.
The digital health for cardiovascular market research report is one of a series of new reports that provides digital health for cardiovascular market statistics, including digital health for cardiovascular industry global market size, regional shares, competitors with a digital health for cardiovascular market share, detailed digital health for cardiovascular market segments, market trends and opportunities, and any further data you may need to thrive in the digital health for cardiovascular industry. This digital health for cardiovascular market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Digital health for cardiovascular care involves the use of technology to monitor, prevent, and manage heart-related conditions. Its primary goal is to provide real-time data, enhance early detection, improve patient outcomes, and offer personalized, continuous care for individuals with cardiovascular diseases.
The main product types in digital health for cardiovascular care include remote monitoring devices, mobile health applications, diagnostic software, wearable ECG monitors, blood pressure monitors, and biosensors. Remote monitoring devices are wearable or portable technologies that continuously track and transmit heart health data, such as heart rate, ECG, and blood pressure, to healthcare providers for real-time assessment and early intervention. These devices utilize technologies such as artificial intelligence (AI), the Internet of Things (IoT), telemedicine, wearable devices, big data analytics, and blockchain. They are deployed on various platforms, including on-premise and cloud-based systems. These devices are used in applications such as cardiac monitoring, diagnosis and early detection, post-surgical care, preventive care, and rehabilitation management. The primary end-users include hospitals and clinics, homecare settings, ambulatory care centers, and academic and research institutes.
The digital health for cardiovascular care market consists of revenues earned by entities by providing services such as telecardiology consultations, clinical decision support systems, personalized lifestyle and diet coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital health for the cardiovascular care market also includes sales of digital stethoscopes, pulse oximeters, telehealth kits, artificial intelligence (AI)-powered imaging software, and internet of things (IoT)-enabled medication dispensers for cardiac patients. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Digital Health For Cardiovascular Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses digital health for cardiovascular market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for digital health for cardiovascular? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital health for cardiovascular market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Remote Monitoring Devices; Mobile Health Applications; Diagnostic Software; Wearable ECG Monitors; Blood Pressure Monitors; Biosensors2) By Technology: Artificial Intelligence (AI); Internet Of Things (IoT); Telemedicine; Wearable Devices; Big Data Analytics; Interoperable Health Data Platforms
3) By Deployment: On-Premise; Cloud
4) By Application: Cardiac Monitoring; Diagnosis And Early Detection; Post-Surgical Care; Preventive Care; Rehabilitation Management
5) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Care Centers; Academic And Research Institutes
Subsegments:
1) By Remote Monitoring Devices: Implantable Loop Recorders; Holter Monitors; Mobile Cardiac Telemetry Devices; Patch Monitors2) By Mobile Health Applications: Heart Rate Monitoring Apps; Blood Pressure Monitoring Apps; Medication Adherence Apps; Diet And Lifestyle Management Apps
3) By Diagnostic Software: Electrocardiogram (ECG) Interpretation Software; Artificial intelligence (AI)-Powered Diagnostic Tools; Cardiac Imaging Analysis Software; Risk Assessment Tools
4) By Wearable Electrocardiogram (ECG) Monitors: Smartwatches With Electrocardiogram (ECG) Functionality; Chest Strap Electrocardiogram (ECG) Monitors; Wristband Electrocardiogram (ECG) Monitors; Clothing-Integrated Electrocardiogram (ECG) Sensors
5) By Blood Pressure Monitors: Arm Cuff Monitors; Wrist Cuff Monitors; Cuffless Continuous BP Monitors; Wireless Blood Pressure (BP) Monitors
6) By Biosensors: Implantable Biosensors; Skin Patch Biosensors; Sweat-Based Sensors; Multi-Parameter Biosensors
Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Philips Healthcare; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Biotronik SE & Co. KG; LivaNova PLC; HeartFlow Inc.; Viz.ai Inc.; Bardy Diagnostics Inc.; Ultromics Limited; RSIP Vision Ltd.; Cardiologs Technologies SAS; Aktiia SA; FibriCheck; Cleerly Inc.; AliveCor Inc.; iRhythm Technologies Inc.; Preventice Solutions (Boston Scientific); Eko Health Inc.; BioTelemetry Inc.; Withings Health Solutions
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Digital Health for Cardiovascular market report include:- Abbott Laboratories
- Medtronic plc
- Siemens Healthineers AG
- Philips Healthcare
- GE HealthCare Technologies Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Biotronik SE & Co. KG
- LivaNova PLC
- HeartFlow Inc.
- Viz.ai Inc.
- Bardy Diagnostics Inc.
- Ultromics Limited
- RSIP Vision Ltd.
- Cardiologs Technologies SAS
- Aktiia SA
- FibriCheck
- Cleerly Inc.
- AliveCor Inc.
- iRhythm Technologies Inc.
- Preventice Solutions (Boston Scientific)
- Eko Health Inc.
- BioTelemetry Inc.
- Withings Health Solutions
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 60.99 Billion |
| Forecasted Market Value ( USD | $ 137.87 Billion |
| Compound Annual Growth Rate | 22.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |


